abstract |
The present invention relates to a novel 4'-methanesulfonyl-biphenyl derivative having a structure of formula 1 and its pharmaceutically acceptable salts as a highly selective cyclooxygenase-2 inhibitor, formula (I); wherein, R?1 and R2¿ are defined in this specification respectively. |